Researchers from The Tisch Cancer Institute at Mount Sinai Icahn School of Medicine in New York identified a protein that may be an unexplored target to develop new cancer therapies.
The protein is called kinase suppressor of Ras or KSR, is a pseudoenzyme that plays an important role in the transmission of signals in the cell, which helps determine whether cells grow, divide or die, the researchers said in a press release. According to the scientists, targeting this protein could lead to improved therapeutic outcomes in cancers, such as lung and pancreatic cancers. Read more . . .